Market cap
$8.3m
End-of-day close multiplied by current shares on issue.
MEE · NZX
Me Today is an NZX-listed consumer / wellness products company. Its latest covered result is FY26, with HY22 - FY26 of source-backed result history on Annolyse.
Latest result
FY26, released 27 August 2026
| Metric | Value | Change |
|---|---|---|
| Revenue | $6.5m | ↓ -12.4% |
| NPAT | $2.7m | ↑ +145.0% |
| Operating cash flow | -$1.3m | ↓ -40.0% |
| Net debt | $0.42m | ↓ -97.1% |
| ROE % | n/m | — |
| PBT | -$1.5m | ↑ +75.0% |
| Debtor days | 125Unprecedented high debtor days. 125d; 4-period range 40d to 103d. Debtor days: 125.0 days, unprecedented high; 4-period mean 71.6 days, range 40.3 days-102.7 days. | ↑ +88.0% |
| Inventory days | 149Outside range low inventory days. 149d; 3-period range 548d to 741d. Inventory days: 148.6 days, below normal range; 3-period mean 657.4 days, range 548.0 days-740.7 days. | ↓ -72.9% |
| Total assets | $7.3m | ↓ -51.8% |
Source: latest published briefing (FY26, released 27 August 2026). Change compares against the prior equivalent period: FY25, released 28 August 2025.
Valuation
Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.
The latest close and share count context for the market price.
Market cap
$8.3m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
3.07x
Recent market cap compared with trailing earnings.
EPS
0.02
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not available for this company right now.
P/B
3.31x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Chat
Ask follow-up questions about Me Today's latest result and company history.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Financial history
The latest period is shown first.
| Metric | FY2612 MONTHS27 August 2026 | HY266 MONTHS26 February 2026 | FY2512 MONTHS28 August 2025 | HY256 MONTHS28 February 2025 | FY2412 MONTHS29 August 2024 | HY246 MONTHS28 February 2024 | FY2312 MONTHS29 August 2023 | HY236 MONTHS1 March 2023 | FY2112 MONTHS29 August 2022 | HY226 MONTHS29 November 2021 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.5m | $2.6m | $7.5m | $3.7m | $5m | $2.3m | $7.9m | $3.6m | $8.3m | $2.4m | Chart |
| Revenue growth % | 36.2% | -31.7% | 48.1%Outside range high revenue growth. 48.1%; 3-period range -36.2% to 14.7%. Revenue growth: 48.1%, above normal range; 3-period mean -8.8%, range -36.2%-14.7%. | 64.2% | -36.2% | -36.8% | -4.7% | 49.0% | 14.7% | 469.6% | Chart
|
| Operating profit | — | -$0.83m | -$4.8m | -$1.8m | -$4.5m | -$2.2m | -$5.2m | -$3.1m | -$5.7m | -$1.8m | Chart |
| Operating profit margin % | — | -32.4% | -63.8% | -47.9% | -89.1% | -97.7% | -65.3% | -85.4% | -68.3% | -75.6% | Chart |
| PBT | -$1.5m | -$0.9m | -$6m | -$2.4m | -$11.3m | -$7.3m | -$13m | -$5.8m | — | -$2.8m | Chart |
| NPAT | $2.7m | $3.2m | -$6m | -$2.4m | -$11.3m | -$7.3m | -$13m | -$5.8m | — | -$2.8m | Chart |
| Operating cash flow | -$1.3m | -$1m | -$0.94m | -$1m | -$3.1m | -$1.9m | -$5.6m | -$4.6m | -$11.7m | -$4.6m | Chart |
| OCF / Operating profit % | — | 120.8% | 19.7% | 58.5% | 69.4% | 86.4% | 107.9% | 150.9% | 207.5% | 253.3% | Chart |
| FCF pre-lease | — | -$1.1m | -$0.94m | -$1.1m | -$3.1m | -$1.9m | -$5.6m | -$4.7m | -$12.1m | -$4.8m | Chart |
| ROE % | n/m | n/m | n/m | n/m | n/m | n/m | n/m | -30.5% | -81.1% | -9.9% | Chart |
| Net debt | $0.42m | $0.02m | $14.5m | $14m | $12.5m | $13.7m | $11.5m | $10m | $6.9m | $10.9m | Chart |
| Net debt / Operating profit | — | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | Chart |
| Debtor days | 125Unprecedented high debtor days. 125d; 4-period range 40d to 103d. Debtor days: 125.0 days, unprecedented high; 4-period mean 71.6 days, range 40.3 days-102.7 days. | 114 | 67 | 91 | 103 | 170 | 77 | 86 | 40 | 145 | Chart
|
| Inventory days | 149Outside range low inventory days. 149d; 3-period range 548d to 741d. Inventory days: 148.6 days, below normal range; 3-period mean 657.4 days, range 548.0 days-740.7 days. | 174 | 548 | 655 | n/m | n/m | 683 | 791 | 741 | n/m | Chart
|
| Total assets | $7.3m | $6.6m | $15.2m | $19m | $21.5m | $20.7m | $27m | $33.9m | $39.5m | $46.2m | Chart |
Reference: annolyse.ai/companies/mee
Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.
These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.
Reported revenue across covered periods.
Like-period revenue growth where comparable.
Company-specific earnings measure where disclosed.
EBITDA-equivalent margin where revenue and earnings are source-backed.
Statutory profit after tax.
Cash generated from operations.
Additional filing-backed metrics for this company. Each point links to the relevant published briefing.
Operating cash flow less capex before leases.
Return on equity.
Borrowings less cash; negative values indicate net cash.
Receivables days where the working-capital inputs are source-backed.
Inventory days where the working-capital inputs are source-backed.
Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.
The setup & the reality
The latest result is checked against what the prior briefing said to watch.
Historical setup
Previous analysisHY26Result releasedAnnolyse analysis published
From King Honey disposal flipped NPAT to NZ$3.2m while continuing revenue fell 31.7%
The release reiterates a stated target of gross revenue exceeding NZ$6.5m for FY26. HY26 reported revenue annualises to roughly NZ$5.1m, leaving a meaningful gap to the target — the implied required step-up is a 27.3% lift on the annualised base, and H1 has just declined 31.7% year-on-year. Management cites 21% growth in continuing-operations gross revenue versus prior, but the statutory revenue line shows a decline, so the framing depends on which baseline is used.
The supplied second-half-shape context (HY25 at 50.1% of FY25 revenue) implies no meaningful H2 weighting historically, so reaching the NZ$6.5m gross target requires a step-change in H2 trading rather than a normal seasonal lift. The release does not provide a bridge for that step-up.
Open questions
This briefing cannot assess whether the FY26 NZ$6.5m gross-revenue target is supported by signed orders, channel commitments, or pipeline because no forward-work disclosure is provided.
Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.
Me Today Limited audited FY26 annual report
FY26 / financial reportFY25 comparative in FY26 audited report (re-presented)
FY25 / financial reportPeer context
These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.
Archive
The full chronological archive contains every published result briefing.
FY26 · Released 27 August 2026
Source-reviewed annual statements; NZD reporting currency and matching FY25 comparative bases retained.
HY26 · Released 26 February 2026
A NZ$4.1m discontinued-operation gain funded a balance-sheet reset, but continuing operations stayed loss-making on a sharply lower revenue base.
FY25 · Released 28 August 2025
The NZ$2.6m capital raised is relevant to debt headroom, while borrowings and gearing remain the direct evidence.
HY25 · Released 28 February 2025
Revenue grew 64.2% and losses improved 66.5%, yet equity dropped 72.5% and cash conversion of 58.5% sits below the 152.9% historical mean.
FY24 · Released 29 August 2024
China manuka demand weakness pushed revenue below the historical baseline, leaving equity of NZ$3.6m against NZ$15.4m of gross borrowings.
HY24 · Released 28 February 2024
EBITDA loss narrowed 27.7% but a customer write-down deepened the NPAT loss to NZ$7.3m and forced a debt restructure plan.
Get the next Me Today result briefing and five-year history updates by email.